Vermont Center fo Cancer Medicines & Blood Disorders
Vermont Center fo Cancer Medicines & Blood Disorders
endcapYour VisitmiddleYour TeammiddleNewly DiagnosedmiddleTypes of CancermiddleCancer TreatmentmiddleTestingmiddleCancer NewsmiddleClinical TrialsmiddleSupport & Resourcesendcap
Welcome Our Mission Appointments Emergencies & Phone Calls Insurance & Billing Locations Prescription Refills Patient Bill of Rights Privacy Policy Website Information
Johannes C. Nunnink, M.D. Dennis A. Sanders, M.D. Christian A. Thomas, M.D. Paul S. Unger, M.D. Christine Suratt, ANP
What is Cancer? Diagnosing Cancer Introduction to Cancer Treatment Optimizing Treatment Questions to Ask A Word about Clinical Trials Getting a Second Opinion
General Cancer Information Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Cervical Cancer Colon Cancer Esophageal Cancer Gastric Cancer Head & Neck Cancer Hodgkin's Lymphoma Leukemia Lung Cancer Melanoma Multiple Myeloma
More...
Non-Hodgkin's Lymphoma Ovarian Cancer Pancreatic Cancer Prostate Cancer Rectal Cancer Renal Cancer Sarcoma Uterine Cancer Skin Cancer Testicular Cancer Thyroid Cancer
Treatment Overview Chemotherapy Radiation Therapy Surgery Hormonal Therapy Targeted Therapy Stem Cell Transplantation Side Effects of Treatment Complementary & Alternative
Overview Screening Tools Diagnostic & Monitoring Tests
Latest Cancer News Anal Cancer Bladder Cancer Bone Cancer Brain & CNS Breast Cancer Cervical Cancer Colon Cancer Complementary Alternative Medicine Esophageal Cancer Gastric Cancer Gene Therapy Head & Neck Cancer HIV Related Cancers Hodgkin's Lymphoma
More...
Liver Cancer Lung Cancer - Non-Small Cell Lung Cancer - Small Cell Malignant Mesothelioma Melanoma Multiple Myeloma Myelodysplastic Syndromes Neuroblastoma Non-Hodgkin's Lymphoma Ovarian Cancer Pancreatic Cancer Prostate Cancer Rectal Cancer Renal Cancer Retinoblastoma
More...
Screening & Prevention Skin Cancer Stem Cell Transplant Supportive Care Testicular Cancer Thyroid Cancer Uterine Cancer Vaginal Cancer
Introduction What Are Clinical Trials? Phases of Clinical Trials How Are Clinical Trials Conducted? Clinical Trials Safeguards Participating in Clinical Trials The Cost of Clinical Trials Finding Specific Clinical Trials The Future of Clinical Trials Clinical Trials Database
Overview Caregivers Healing Environments Support Groups Journaling Birth Control and Sexuality Home Health Financial & Insurance Issues Advanced Directives Inspiration Movement & Exercise Life after Treatment Online Resources
floatmenu_left Home Home   Drug Dictionary Drug Dictionary   Cancer Dictionary Cancer Dictionary   Links Links   Contact Us Contact Us floatmenu_right
Vermont Center fo Cancer Medicines & Blood Disorders
E-mail this page   Print this page
Section Title

What is the purpose of diagnostic tests?

Cancer patients undergo many different types of tests in order to accurately diagnose their disease, determine their prognosis, and monitor their cancer for progression or recurrence.

The term “diagnostic test” can be misleading, as these tests are not used only for diagnosing cancer, but also for monitoring cancer progression. There are many reasons for employing diagnostic tests depending on whether the disease is active or progressing, being treated, or in remission. Diagnostic tests may be used to:

  • Diagnose primary disease—identify the disease the first time it occurs
  • Identify cancer subtype—some cancers are divided into subtypes that are more or less aggressive; identification of a more aggressive subtype may influence the type of treatment proposed
  • Predict prognosis—test results may indicate chance of cure, based on outcomes of other patients with similar results
  • Direct treatment—cancer is many different diseases, all of which respond differently to various treatments. A diagnosis that accurately identifies the type of cancer and predicts prognosis will also help to identify the type of treatment that maximizes chance of cure.
  • Evaluate response to treatment—some tests show whether the cancer is responding to treatment
  • Detect minimal residual disease—cancer cells that remain after treatment is completed are called (MRD). Detection of MRD may indicate a higher likelihood of recurrence.
  • Monitor remission or progression—if a cancer is in remission, frequent tests may help detect the cancer if it returns and/or determine whether it is progressing
  • Screen at-risk individuals—identifying abnormalities in cells or the DNA of cells of asymptomatic (healthy) individuals may indicate an increased risk (although not a certainty) of developing disease


Pathology Tests: Pathology tests involve microscopic evaluation of abnormal cells.

Diagnostic Imaging: Diagnostic imaging involves visualization of abnormal masses using high-tech machines that create images. Examples of diagnostic imaging include x-rays, computed tomography (CT) scans, positron emission tomography (PET) scans, magnetic resonance imaging (MRI), and combined PET/CT scans.

Blood Tests: Blood tests measure substances in the blood that may indicate how advanced the cancer is or other problems related to the cancer.

Tumor Markers: Tumor marker tests detect substances in blood, urine, or other tissues that occur in higher than normal levels with certain cancers.

Genomics: Special laboratory evaluation of DNA involves the identification of the genetic make-up-the DNA-of the abnormal cells.